The bioanalysis market - France

Bioanalysis consists of analyzing biomolecules to identify, quantify and characterize them, in order to obtain marketing authorization for a product. The origins of bioanalysis in pharmacy stem from the emergence in Europe of drugs manufactured using biotechnologies, and corresponding to the label " Products manufactured by recombinant DNA techniques " in the European Pharmacopoeia. The methods used to analyze biomolecules are markedly different from those used for conventional analysis of relatively small organic compounds. This has given rise to a new branch of analysis: bioanalysis. The bioanalysis market covers three sectors: healthcare, agri-food and the environment. In reality, it involves analytical subcontracting for pharmaceutical laboratories, cosmetics manufacturers, agri-food companies and others. This is seen as a rather dynamic market, and while its average annual growth rate over the 2012-2019 period was in double digits, this has remained positive despite the health crisis. Since 2020, the Covid-19 crisis has opened up new growth prospects for this market, due to increased risk and consumers' growing mistrust of their food and pharmaceutical products. This dynamism revolves mainly around a small number of companies that are leaders in their field: Eurofins Scientific is even the world leader in the sector. Eurofins Scientific, along with other players such as Phytocontrol and Carso, continue to expand internationally, thanks to new laboratories and acquisitions aimed at strengthening their position in the market.external growth operations aimed at reinforcing expertise already mastered by these structures or, on the contrary, helping them to develop a more complete and differentiated offer.